| Display title | Chemistry:Mardepodect |
| Default sort key | Mardepodect |
| Page length (in bytes) | 6,223 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 324354 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>AnLinks |
| Date of page creation | 10:01, 2 May 2023 |
| Latest editor | imported>AnLinks |
| Date of latest edit | 10:01, 2 May 2023 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Mardepodect (developmental code name PF-2545920) is a drug which was developed by Pfizer for the treatment of schizophrenia. It acts as a phosphodiesterase inhibitor selective for the PDE10A subtype. The PDE10A enzyme is expressed primarily in the brain, mostly in the striatum, nucleus accumbens and... |
